Browsing by Author Kestell, P.

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-Nov-2003Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)Zhou, S. ; Ching, L.-M.; Baguley, B.C.; Kestell, P.; Palmer, B.D.; Lu, J.
25-Feb-2003Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detectionZhou, S. ; Li, Y.; Kestell, P.; Paxton, J.W.
25-Sep-2004Determination of the investigational anti-cancer drug 5,6- dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: Application to transport studiesZhou, S. ; Feng, X.; Kestell, P.; Baguley, B.C.; Paxton, J.W.
Aug-2005Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: A molecular modelling studyPaxton, J.W.; Kestell, P.; Chiang, D.; Zhou, S. ; Lewis, D.F.V.
1-Jun-2003Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acidZhou, S. ; Kestell, P.; Baguley, B.C.; Paxton, J.W.
Jan-2005Transport of thalidomide by the human intestinal Caco-2 monolayersZhou, S. ; Li, Y.; Kestell, P.; Schafer, P.; Chan, E. ; Paxton, J.W.
Apr-2005Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4- acetic acid and its acyl glucuronide by human intestinal Caco-2 cellsZhou, S. ; Feng, X.; Kestell, P.; Paxton, J.W.; Baguley, B.C.; Chan, E.